Eugene_Ma_665x402

Change is here!

See change™ in protein characterization.

Our CTO, Eugene Ma, is on hand to answer any questions on your application, sample or our technology. Submit your question and he will get back to you directly.

AQS3_TM_pro-75

The Next Generation in Protein Characterization

The AQS3pro launches a new era in IR spectroscopy and protein characterization, bringing repeatable, high sensitivity, automated measurements to every stage of the biopharmaceutical pipeline. Powered by Microfluidic Modulation Spectroscopy (MMS), the AQS3pro measures the secondary structure of proteins over nearly four decades of concentration, from 0.1 mg/ml to over 200 mg/ml. Driven by the industry-leading AQS3delta Analytical Software package, it streamlines and simplifies 5 key measurements:

Aggregation | Quantitation | Stability | Structure | Similarity

See change in your protein, in your workflow, and in your efficiency.

Visit the product page to learn more.

Watch Our Webinar Replay

Load samples and walk away.

The widest concentration range to characterize biotherapeutics.

Generate precise, high sensitivity data.

Analyze and understand protein behavior.

Bioprocess Summit, Aug 21, Boston, MA

Well Characterized Biological & Biological Assays, Oct 24 – 26, Arlington, VA

AAPS, Nov 4 - 8, Washington, DC

PEGS Summit Europe, Nov 12th - 16th 2018, Lisbon Congress Center, Lisbon, Portugal

RedShiftBio™

RedShiftBio™ is an innovative provider of analytical instrumentation for the research, development and manufacturing of protein therapeutic drugs.

Read More

Learn More

MMS For Protein Therapeutic Drug Analysis

Enhanced Protein Structural Characterization using MMS

Contact Us

RedShift BioAnalytics Inc.

131 Middlesex Turnpike
Burlington, MA 01803

T: 781.345.7300
F: 781-345-7301
E: info@redshiftbio.com

RedShift™, RedShiftBio™,  See Change™, and AQS3™ are trademarks of RedShift BioAnalytics, Inc.